Trade Amarin Corporation plc - AMRN CFD

Add to favourite

0.5689

3.83%

0.0096

Low: 0.5689

High: 0.5808

Market Trading Hours* (UTC) Open now
Closes on Thursday at 21:00

Mon - Fri: 14:30 - 21:00

Summary
Historical Data

Trading сonditions

Spread

0.0096

Long position overnight fee

-0.023512%

Short position overnight fee

0.00129%

Overnight fee time

22:00 (UTC)

Min traded quantity

Currency

USD

Margin

5.00%

Stock exchange

United States of America

Commission on trade

Key Stats

Prev. Close	0.5479
Open	0.57
1-Year Change	-57.69%
Day's Range	0.5689 - 0.5808

Last Week
Last Month
Last Year
Last two Years
Max

Daily
Weekly
Monthly

Date	Close	Change	Change (%)	Open	High	Low
Jan 29, 2025	0.5479	-0.0440	-7.43%	0.5919	0.5919	0.5471
Jan 28, 2025	0.5817	-0.0068	-1.16%	0.5885	0.5962	0.5704
Jan 27, 2025	0.5739	-0.0372	-6.09%	0.6111	0.6385	0.5739
Jan 24, 2025	0.6141	0.0003	0.05%	0.6138	0.6639	0.6025
Jan 23, 2025	0.6265	0.0868	16.08%	0.5397	0.6345	0.5397
Jan 22, 2025	0.5381	-0.0283	-5.00%	0.5664	0.5684	0.5375
Jan 21, 2025	0.5580	0.0095	1.73%	0.5485	0.5602	0.5314
Jan 17, 2025	0.5438	0.0132	2.49%	0.5306	0.5616	0.5306
Jan 16, 2025	0.5517	0.0132	2.45%	0.5385	0.5547	0.5300
Jan 15, 2025	0.5531	0.0472	9.33%	0.5059	0.5564	0.4980
Jan 14, 2025	0.5110	-0.0075	-1.45%	0.5185	0.5282	0.5030
Jan 13, 2025	0.5130	-0.0207	-3.88%	0.5337	0.5436	0.5013
Jan 10, 2025	0.5478	0.0092	1.71%	0.5386	0.5641	0.5216
Jan 8, 2025	0.5485	0.0100	1.86%	0.5385	0.5631	0.5120
Jan 7, 2025	0.5441	0.0276	5.34%	0.5165	0.5487	0.5165
Jan 6, 2025	0.5176	-0.0088	-1.67%	0.5264	0.5444	0.5026
Jan 3, 2025	0.5214	0.0008	0.15%	0.5206	0.5334	0.4969
Jan 2, 2025	0.5132	0.0442	9.42%	0.4690	0.5347	0.4690
Dec 31, 2024	0.4705	0.0372	8.59%	0.4333	0.4767	0.4254
Dec 30, 2024	0.4385	0.0017	0.39%	0.4368	0.4432	0.4285

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission

1:1
2:1
3:1
5:1
10:1
20:1

Leverage

20:1

20
100
500
1000
10000

Investment

Trade size (Leverage x Investement):

Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Amarin Corporation plc Company profile

Amarin Corporation (AMRN) is a clinical-stage biopharmaceutical company focused on the commercialisation and improvement of therapeutics to cure and deal with cardiovascular diseases.

Established in 1989, Amarin is headquartered in Dublin, Ireland, and operates in several European countries, the United States, Canada, Lebanon and the United Arab Emirates.

The company’s lead commercial product VASCEPA (icosapent ethyl) is a prescription-only omega-3 fatty acid product. Taken as an adjunct to diet, it reduces triglyceride levels in adult patients suffering from severe hypertriglyceridemia. The drug helps to address cardiovascular risk for millions of patients.

VASCEPA was launched in the United States in 2013, but gained wider recognition in 2019 as the US Food and Drug Administration (FDA) approved Amarin for a broader indication for cardiovascular risk reduction in studied high-risk patients. It has also got approval from the European Commission to reduce the risks for cardiac patients.

Amarin still prices VASCEPA at a considerably lower level than other new drugs of its category.

Formerly known as Ethical Holdings, the company changed its name to Amarin Corporation in 1999. The company went public in July 2019. It trades on the Nasdaq under the ticker ‘AMRN’.

Industry:

Bio Therapeutic Drugs

First Floor, Block 3, The Oval,
Shelbourne Road, Ballsbridge
DUBLIN
IE